Levosimendan Use Reduces Matrix Metalloproteinase-2 in Patients with Decompensated Heart Failure

Author： Tziakas Dimitrios   Chalikias Georgios   Hatzinikolaou Helen   Stakos Dimitrios   Papanas Nikolaos   Tentes Ioannis   Kortsaris Alexandros   Maltezos Efstratios   Hatseras Dimitrios   Kaski Juan  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.19, Iss.6, 2005-12, pp. : 399-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levosimendan: A Review of its Use in the Management of Acute Decompensated Heart Failure

By Innes C.A.   Wagstaff A.J.  

Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. : 2651-2671

Adis International

Access to resources Recommend Favorite

Doxorubicin: Decompensated heart failure treated with levosimendan: case report

By  

Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure

By  

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 435-455

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Treatment of Patients with Decompensated Heart Failure

By Mills R.M.   Hobbs R.E.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 119-125

Adis International

Access to resources Recommend Favorite

Nesiritide: A Review of its Use in Acute Decompensated Heart Failure

By Keating G.M.   Goa K.L.  

Drugs, Vol. 63, Iss. 1, 2003-01 ,pp. : 47-70

Adis International

Access to resources Recommend Favorite